Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "food stagnation resolution" comes from traditional Chinese medicine (TCM), where "food stagnation" describes a pattern of digestive dysfunction caused by overeating, weakened digestive organs (especially the spleen and stomach according to TCM theory), or maladaptive eating habits. The concept encompasses symptoms such as abdominal bloating, distension, constipation, bad breath, belching, and a sense of fullness. "Resolution" refers to the process of therapeutically addressing or relieving these symptoms (for example, through herbal formulas, dietary adjustment, or acupressure). This is not a molecular or receptor target and lacks an identifiable protein, enzyme, or other biomolecular form recognized in biomedical pharmacology[4][8]. Because "food stagnation resolution" is not a molecular entity, receptor, enzyme, or actionable therapeutic target, and instead refers to a syndrome or a desired clinical outcome from a TCM perspective, it does not fit into structured drug target databases based on molecules, receptors, or genes. Thus, this entry should be flagged as incorrect for the purpose of target curation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Food stagnation resolution.